U.S. mass tort: Philips CPAP recall liti… | DrugsMonitor.com
Philips CPAP recall litigation —primer on claims in play, court posture, key deadlines, and a confidential attorney review—not legal advice.
PE-PUR foam, BiPAP, sleep apnea devices, respiratory injury
Philips recalled millions of CPAP, BiPAP, and ventilator devices after degraded polyester-polyurethane (PE-PUR) sound-abatement foam could release particles or volatile chemicals. Users allege respiratory injury, cancer, and other harms.
Recall background
FDA classified the recall as Class I for many units—the most serious level—citing potential toxic and carcinogenic effects from foam breakdown, especially with ozone cleaning or high heat/humidity storage.
Plaintiffs assert design defect, failure to warn, and negligence; defendants dispute injury causation and exposure levels.
FAQ
What is Philips CPAP Device litigation about?
This page summarizes public litigation context and safety background for Philips CPAP recall litigation. It is educational—not a case evaluation for you personally.
Is this page legal advice?
No. DrugsMonitor.com is not a law firm. Nothing here tells you whether you have a claim or what you should do next legally.
How do I request a confidential review?
Use the intake or "Request a confidential review" options on this page. That may route you to a partner firm only when you choose to proceed.